These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22874111)

  • 21. Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy.
    Sawada K; Mizoguchi K; Hishida A; Kaneko E; Koide Y; Nishimura K; Kimura M
    Clin Nephrol; 1996 May; 45(5):289-94. PubMed ID: 8738659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
    Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
    Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.
    Ishii S; Chang HH; Kawasaki K; Yasuda K; Wu HL; Garman SC; Fan JQ
    Biochem J; 2007 Sep; 406(2):285-95. PubMed ID: 17555407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).
    Marrone G; Angelico R; Di Lauro M; Sargentini E; Manzia TM; Tisone G; Mitterhofer AP; Della Morte Canosci D; Tesauro M; Di Daniele N; Noce A
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3134-3141. PubMed ID: 37070916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
    Yamashita S; Saotome M; Satoh H; Kajihara J; Mochizuki Y; Mizuno K; Nobuhara M; Miyajima K; Kumazawa A; Tominaga H; Takase H; Tawarahara K; Wakahara N; Matsunaga M; Wakabayashi Y; Matsumoto Y; Terada H; Sano M; Ohtani H; Urushida T; Hayashi H; Ishii S; Maruyama H; Maekawa Y
    Circ J; 2019 Aug; 83(9):1901-1907. PubMed ID: 31308318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns.
    Lee BH; Heo SH; Kim GH; Park JY; Kim WS; Kang DH; Choe KH; Kim WH; Yang SH; Yoo HW
    J Hum Genet; 2010 Aug; 55(8):512-7. PubMed ID: 20505683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
    Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
    Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
    Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kidney in Fabry's disease.
    Pisani A; Visciano B; Imbriaco M; Di Nuzzi A; Mancini A; Marchetiello C; Riccio E
    Clin Genet; 2014 Oct; 86(4):301-9. PubMed ID: 24645664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-galactosidase A activity levels in Turkish male hemodialysis patients.
    Kalkan Uçar S; Sozmen E; Duman S; Başçi A; Çoker M
    Ther Apher Dial; 2012 Dec; 16(6):560-5. PubMed ID: 23190516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
    Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
    Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p.E66Q mutation in the GLA gene is associated with a high risk of cerebral small-vessel occlusion in elderly Japanese males.
    Nakamura K; Sekijima Y; Nakamura K; Hattori K; Nagamatsu K; Shimizu Y; Yazaki M; Sakurai A; Endo F; Fukushima Y; Ikeda SI
    Eur J Neurol; 2014; 21(1):49-56. PubMed ID: 23724928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: is low α-Gal enzyme activity sufficient to establish the diagnosis of Fabry disease?
    Biagini G; Almeida ACSF; Almeida TVR; Silva CAB; Castro BF; Reche TC; Dabinski AC; Barreto FC
    J Bras Nefrol; 2017; 39(3):333-336. PubMed ID: 29044343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of alpha-galactosidase a gene in Hungarian Fabry patients.
    László A; Török L; Raffai S; Török E; Sallay E; Endreffy E; Morvai L; van Amstel JK
    Ideggyogy Sz; 2012 Jan; 65(1-2):35-9. PubMed ID: 22338844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke and Chronic Kidney Disease in Fabry Disease.
    Tapia D; Kimonis V
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105423. PubMed ID: 33160817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease.
    Esposito P; Caputo C; Repetto M; Somaschini A; Pietro B; Colomba P; Zizzo C; Parodi A; Zanetti V; Canepa M; Eustachi V; Sanguineri F; Mandich P; Viazzi F
    BMC Nephrol; 2023 Nov; 24(1):344. PubMed ID: 37990184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Partial deletion of alpha-galactosidase A gene in a Japanese mutant of Fabry disease].
    Sakuraba H; Bishop DF; Suzuki T; Suzuki Y; Desnick RJ
    No To Hattatsu; 1990 May; 22(3):247-52. PubMed ID: 2163664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening of Fabry disease in patients with chronic kidney disease in Japan.
    Nagata A; Nasu M; Kaida Y; Nakayama Y; Kurokawa Y; Nakamura N; Shibata R; Hazama T; Tsukimura T; Togawa T; Saito S; Sakuraba H; Fukami K
    Nephrol Dial Transplant; 2021 Dec; 37(1):115-125. PubMed ID: 34282462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alpha-galactosidase A gene mutation in a Chinese family with Fabry disease mimicking clinical features of hypertrophic cardiomyopathy].
    Liu HJ; Cao KJ; Li CR; Dai J; Ma JZ; Yong YH; Sun W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):143-7. PubMed ID: 16626582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations.
    Nakagawa N; Sawada J; Sakamoto N; Takeuchi T; Takahashi F; Maruyama JI; Momosaki K; Nakamura K; Endo F; Hasebe N
    J Hum Genet; 2019 Sep; 64(9):891-898. PubMed ID: 31213654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.